Heart failure (HF) is still a global burden which carries substantial risk of morbidity and
mortality. Thus, appropriate approach of diagnosis and layering the prognosis of HF are of …

Background Heart failure (HF) continues to be an illness of daunting proportions with a four-
year mortality touching 50%. Biomarkers for prognosticating patients with heart failure have …

Background The studied associations between serum uric acid (sUA) and cardiovascular
disease (CVD) events have been controversial. We sought to evaluate the association …

The effect of circulating biomarkers in predicting coronary artery disease (CAD) is not fully
elucidated. This study aimed to determine the relationship with CAD and the predictive …

Chronic diseases are diseases of long duration and slow progression. Major NCDs
(cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, rheumatologic …

Aims To assess the incremental value of biomarkers, including N-terminal prohormone of
brain natriuretic peptide (NT-proBNP), high-sensitivity troponin T (hs-TnT), high-sensitivity C …

Background Osteopontin (OPN), a multifunctional glycoprotein, has recently been found to
be an important player in cardiovascular diseases and to be implicated in a variety of acute …

Background Extracellular matrix-degrading proteinases are upregulated in atherosclerotic
lesions and can contribute to subsequent pathological events. In the present nested case …

Cardiovascular disease (CVD) risk screening is performed by multivariate methods relying
on calculators derived from the Framingham study, other epidemiological studies or primary …

Despite the great strides made in secondary cardiovascular (CV) prevention over the past
half century, the residual risk of recurrent ischemic events among patients with acute …